PRC2-mediated repression of tumor suppressor genes, including Cdkn2a (p16INK4A), Cdkn2b (p15INK4B), Gata2 and Egr1, is a critical event in MLL-AF9 AML [22, 23, 43]. The gene discussed is CDKN2B; the disease is acute myeloid leukemia.